Daclizumab is a monoclonal antibody indicated for treating adults with recurrent
multiple sclerosis.
It is also used to prevent organ rejection after
transplantation. How does Daclizumab work?
Daclizumab acts by blocking certain receptors present on T-cells.
The net result is reduction of T-cell responses.T-cells are a kind of
lymphocytes which help to maintain
immunity in our body.
Classification:
Daclizumab belongs to
Immunosuppressant group of drugs.
Disclaimer
All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.